Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Arteaus Therapeutics LLC
Headquarters: Cambridge, MA, United States of America
Website: N/A
Year Founded: 2011
Status: Acquired
BioCentury | Oct 16, 2020
Deals
With Disarm deal, Atlas returns to Lilly to take neuro program forward
Eli Lilly’s acquisition of Disarm marks the second time an Atlas-incubated newco has turned to the pharma to advance its neurology assets. Under the deal, Eli Lilly and Co. (NYSE:LLY)
BioCentury | Aug 17, 2017
Finance
Built to purpose
How build-to-buy deals are reaching an inflection point
BioCentury | Jan 11, 2016
Strategy
Set them free
Why J&J may spin out core assets without claw-back agreements
BioCentury | Oct 6, 2014
Finance
Atlas' next chapter
What splitting from tech team means for Atlas life science portfolio
BioCentury | Jan 20, 2014
Finance
Asset-centric milestone
Lilly-Arteaus deal provides Atlas Venture with first asset-centric graduation
Items per page:
1 - 10 of 20